Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kassler-Taub

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study GroupP Howe, P Phillips, R Saini, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Dose-related efficacy of irbesartan for hypertension: an integrated analysisR A Reeves, C S Lin, K Kassler-Taub, et al.
American Journal of Hypertension|June 2, 1998
Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study InvestigatorsK Kassler-Taub, T Littlejohn, W Elliott, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.
American Journal of Hypertension|September 10, 1999
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionM Kochar, R Guthrie, J Triscari, et al.
British Journal of Anaesthesia|November 25, 2011
Simulated evaluation of a non-Luer safety connector system for use in neuraxial proceduresR Onia, Y Wu, V Parvu, et al.
Journal of Human Hypertension|May 14, 1998
A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertensionA Mimran, L Ruilope, L Kerwin, et al.
Atherosclerosis|June 1, 1993
Pravastatin experience in elderly and non-elderly patientsM J Mellies, A R DeVault, K Kassler-Taub, et al.
Blood Pressure|April 29, 1998
Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertensionK O Stumpe, D Haworth, C Hoglund, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study GroupP Howe, P Phillips, R Saini, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Dose-related efficacy of irbesartan for hypertension: an integrated analysisR A Reeves, C S Lin, K Kassler-Taub, et al.
American Journal of Hypertension|June 2, 1998
Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study InvestigatorsK Kassler-Taub, T Littlejohn, W Elliott, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.
American Journal of Hypertension|September 10, 1999
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionM Kochar, R Guthrie, J Triscari, et al.
British Journal of Anaesthesia|November 25, 2011
Simulated evaluation of a non-Luer safety connector system for use in neuraxial proceduresR Onia, Y Wu, V Parvu, et al.
Journal of Human Hypertension|May 14, 1998
A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertensionA Mimran, L Ruilope, L Kerwin, et al.
Atherosclerosis|June 1, 1993
Pravastatin experience in elderly and non-elderly patientsM J Mellies, A R DeVault, K Kassler-Taub, et al.
Blood Pressure|April 29, 1998
Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertensionK O Stumpe, D Haworth, C Hoglund, et al.
Pageof 1